Cognex


Also found in: Wikipedia.

Cognex

(kŏg′nĕks′)
A trademark for the drug tacrine hydrochloride.

Cognex

a trademark for a cognition enhancer and analeptic (tacrine). It is a reversible cholinesterase inhibitor and may have a role in early Alzheimer's disease to improve some cognitive functions. It does not affect the prognosis of the disease.

Cognex®

Neurology An agent that transiently slows the mental decline in Alzheimer's Pts. See Alzheimer's disease.
References in periodicals archive ?
Cognex is the world's leading supplier of machine vision systems, or computers that can "see.
Cognex Corporation has announced that Electro Scientific Industries (ESI) has entered into a settlement and license agreement with Cognex, resolving a dispute related to ESI's alleged infringement of a U.
District Court in Las Vegas ruled in favor of Cognex Corp.
Cognex Corporation (NASDAQ: CGNX), has introduced VisionPro, an ActiveX-based software development environment that dramatically speeds the development of advanced vision applications.
They're both roles he's assumed recently, the former for a magazine cover photo shoot and the latter to hand out bonuses - cold cash straight from the freezer compartment of a restored 1950s ice cream truck - at a company picnic for Cognex.
9 /PRNewswire/ -- Warner-Lambert Company (NYSE: WLA) announced today that clearance has been received for the marketing of Cognex (tacrine hydrochloride).
Cognex Corporation (NASDAQ: CGNX) announced today that Richard A.
March 18 /PRNewswire/ -- The Peripheral and Central Nervous System Drugs Advisory Committee today recommended approval of Cognex (tacrine or THA), the Alzheimer's disease drug being developed by the Parke-Davis division of Warner-Lambert Company.
27 /PRNewswire/ Warner-Lambert Company (NYSE: WLA) today issued the following statement on the results of the previously reported clinical trial involving its experimental Alzheimer's disease drug Cognex (tacrine or THA) published in Thursday's New England Journal of Medicine.
Cognex Corporation (NASDAQ: CGNX) is scheduled to present at the Needham & Company 13th Annual Growth Conference at The New York Palace Hotel in New York, NY.
Cognex machine vision technology is used worldwide to perform automated inspection of materials that are manufactured in a continuous fashion such as metals paper nonwovens, and plastic film.
Cognex Corporation designs, develops, manufactures and markets machine vision sensors and systems, or devices that can "see.